Document Detail

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo.
MedLine Citation:
PMID:  22829966     Owner:  NLM     Status:  PubMed-not-MEDLINE    
In the continuing search for effective cancer treatments, we report the rational engineering of a multifunctional nanoparticle that combines traditional chemotherapy with cell targeting and anti-adhesion functionalities. Very late antigen-4 (VLA-4) mediated adhesion of multiple myeloma (MM) cells to bone marrow stroma confers MM cells with cell-adhesion-mediated drug resistance (CAM-DR). In our design, we used micellar nanoparticles as dynamic self-assembling scaffolds to present VLA-4-antagonist peptides and doxorubicin (Dox) conjugates, simultaneously, to selectively target MM cells and to overcome CAM-DR. Dox was conjugated to the nanoparticles through an acid-sensitive hydrazone bond. VLA-4-antagonist peptides were conjugated via a multifaceted synthetic procedure for generating precisely controlled number of targeting functionalities. The nanoparticles were efficiently internalized by MM cells and induced cytotoxicity. Mechanistic studies revealed that nanoparticles induced DNA double-strand breaks and apoptosis in MM cells. Importantly, multifunctional nanoparticles overcame CAM-DR, and were more efficacious than Dox when MM cells were cultured on fibronectin-coated plates. Finally, in a MM xenograft model, nanoparticles preferentially homed to MM tumors with ∼10 fold more drug accumulation and demonstrated dramatic tumor growth inhibition with a reduced overall systemic toxicity. Altogether, we demonstrate the disease driven engineering of a nanoparticle-based drug delivery system, enabling the model of an integrative approach in the treatment of MM.
T Kiziltepe; J D Ashley; J F Stefanick; Y M Qi; N J Alves; M W Handlogten; M A Suckow; R M Navari; B Bilgicer
Related Documents :
22291036 - Invasive matrix degradation at focal adhesions occurs via protease recruitment by a fak...
22404936 - Epinephrine modulates bcam/lu and icam-4 expression on the sickle cell trait red blood ...
22472216 - Hydrogen peroxide-inducible clone 5 (hic-5) as a potential therapeutic target for vascu...
22423616 - Pleiotrophin expression and role in physiological angiogenesis in vivo: potential invol...
11694446 - Trefoil factor family-peptides promote migration of human bronchial epithelial cells: s...
15625106 - Induction, differentiation, and remodeling of blood vessels after transplantation of bc...
Publication Detail:
Type:  Journal Article     Date:  2012-04-20
Journal Detail:
Title:  Blood cancer journal     Volume:  2     ISSN:  2044-5385     ISO Abbreviation:  Blood Cancer J     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-07-25     Completed Date:  2012-10-02     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101568469     Medline TA:  Blood Cancer J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e64     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reactive oxygen species in the signaling and adaptation of multicellular microbial communities.
Next Document:  Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.